Date: 2013-02-11
Type of information:
Compound: webinar projects on oncology, technology, biomarkers and late phase development
Company: Icon (Ireland) DIA
Therapeutic area: Cancer - Oncology
Type agreement: collaboration
Action mechanism:
Disease:
Details: Icon, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has announced a collaboration with DIA (Drug Information Association) to deliver the first solution-provider webinar,which offers free access toknowledge and innovative solutions to overcome some of the key challenges in medical product development. The company will collaborate with DIA’s newly-created Solution Provider Webinar Program. Icon experts, together with leading scientists and thought leaders from the biopharma industry, will present four 90-minute webinars throughout 2013. The webinars are free to DIA members and will feature topics including oncology, strategies for late phase development, biomarkers and technology as an enabler of clinical development services.
The first webinar, taking place on March 11, 2013, is entitled Oncology Clinical Trial Endpoints – Keys to Maximizing Success in your Development Programs. Speakers include:
• Dr. Jamal Gasmi, Vice President & Global Leader - Oncology & Haematology Drug Development, Icon Clinical Research
• Dr. Gregory V. Goldmacher, Director, Medical & Scientific Affairs, Head of Oncology Imaging, Icon Medical Imaging
• Dr. James J. Conklin, Senior Vice President, Medical and Scientific Affairs, Icon Medical Imaging
• Dr. Samuel Blackman, Executive Director, Head of Translational Medicine, Seattle Genetics.
Financial terms:
Latest news:
